Verona Pharma
VRNA
$13.00
Share price
-2.69%
Change (1 day)
-33.09%
Change (1 year)
Categories
Earnings for Verona Pharma (VRNA)
Earnings in 2023 (TTM): -$51.84 M
According to Verona Pharma's latest financial reports the company's current earnings (TTM) are -$51.84 M. an increase over its 2022 earnings that were of -$67.93 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Verona Pharma from 2017 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$51.84 M | -23.69% |
| 2022 | -$67.93 M | 22.95% |
| 2021 | -$55.25 M | |
| 2019 | -$66.4 M | 51.17% |
| 2018 | -$43.93 M | -9.2% |
| 2017 | -$48.38 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.17 M | -95.83% | Bahamas |
 NRC Health
NRC | $40.82 M | -178.75% | 🇺🇸 USA |